Works by Shi, Xiaojin


Results: 38
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27

    Population Pharmacokinetics and Exposure–Response Analysis for the CTLA‐4 Inhibitor Tremelimumab in Metastatic NSCLC Patients in the Phase III POSEIDON Study.

    Published in:
    Clinical Pharmacology & Therapeutics, 2023, v. 114, n. 6, p. 1375, doi. 10.1002/cpt.3063
    By:
    • He, Jimmy Zhijian;
    • Duval, Vincent;
    • Jauslin, Petra;
    • Gonçalves, Antonio;
    • Abegesah, Aburough;
    • Fan, Chunling;
    • Lim, KyoungSoo;
    • Song, Xuyang;
    • Chen, Cecil;
    • Shi, Xiaojin;
    • Mann, Helen;
    • Krug, Lee;
    • Ren, Song;
    • Phipps, Alex;
    • Gibbs, Megan;
    • Zhou, Diansong
    Publication type:
    Article
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38